We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$148B
AUM Growth
+$13.7B
Cap. Flow
+$2.5B
Cap. Flow %
1.69%
Top 10 Hldgs %
25.2%
Holding
4,104
New
267
Increased
1,933
Reduced
1,554
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Financials 9.11%
3 Healthcare 8.03%
4 Industrials 6.97%
5 Consumer Discretionary 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DDD icon
3151
3D Systems Corp
DDD
$601M
$431K ﹤0.01%
97,089
-18,907
-16% -$93K
FRPH icon
3152
FRP Holdings
FRPH
$425M
$430K ﹤0.01%
14,000
STPZ icon
3153
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$525M
$428K ﹤0.01%
8,309
+368
+5% +$18.9K
SCPH
3154
DELISTED
scPharmaceuticals
SCPH
$427K ﹤0.01%
85,049
-2,000
-2% -$11.2K
NNY icon
3155
Nuveen New York Municipal Value Fund
NNY
$158M
$427K ﹤0.01%
51,296
+4,500
+10% +$37.6K
ISCV icon
3156
iShares Morningstar Small-Cap Value ETF
ISCV
$710M
$426K ﹤0.01%
6,967
-69
-1% -$4K
PROF
3157
Profound Medical
PROF
$242M
$426K ﹤0.01%
49,980
-15,713
-24% -$131K
BHC icon
3158
Bausch Health
BHC
$2.37B
$426K ﹤0.01%
40,152
+637
+2% +$5.57K
LBTYA icon
3159
Liberty Global Class A
LBTYA
$3.58B
$425K ﹤0.01%
+25,140
New +$459K
GFI icon
3160
Gold Fields
GFI
$35.4B
$425K ﹤0.01%
26,768
-71,922
-73% -$1M
SWBI icon
3161
Smith & Wesson
SWBI
$643M
$425K ﹤0.01%
24,488
-1,393
-5% -$20.1K
SFL icon
3162
SFL Corp
SFL
$1.61B
$425K ﹤0.01%
32,243
+232
+0.7% +$2.92K
IXG icon
3163
iShares Global Financials ETF
IXG
$702M
$425K ﹤0.01%
4,900
+82
+2% +$6.66K
CXE
3164
DELISTED
MFS High Income Municipal Trust
CXE
$424K ﹤0.01%
116,882
+3,549
+3% +$12.7K
SEMR
3165
DELISTED
Semrush
SEMR
$424K ﹤0.01%
+31,988
New +$385K
NPV icon
3166
Nuveen Virginia Quality Municipal Income Fund
NPV
$216M
$424K ﹤0.01%
38,301
IDLV icon
3167
Invesco S&P International Developed Low Volatility ETF
IDLV
$343M
$424K ﹤0.01%
15,093
-2,854
-16% -$79.7K
PBT
3168
Permian Basin Royalty Trust
PBT
$1.56B
$423K ﹤0.01%
34,969
-17,636
-34% -$240K
INTC icon
3169
PUT
Intel
INTC
$527B
$423K ﹤0.01%
9,400
PJUL icon
3170
Innovator US Equity Power Buffer ETF July
PJUL
$1.29B
$422K ﹤0.01%
11,120
-2,146
-16% -$79.5K
FRDM icon
3171
Freedom 100 Emerging Markets ETF
FRDM
$3.43B
$420K ﹤0.01%
12,463
+770
+7% +$24.6K
KEX icon
3172
Kirby Corp
KEX
$7.26B
$420K ﹤0.01%
4,409
-2,436
-36% -$206K
IPAY icon
3173
Amplify Mobile Payments ETF
IPAY
$188M
$419K ﹤0.01%
7,969
-27,172
-77% -$1.3M
ATRO icon
3174
Astronics
ATRO
$4.57B
$418K ﹤0.01%
26,366
KE
3175
Kimball Electronics
KE
$626M
$418K ﹤0.01%
19,288
-251
-1% -$5.67K

Similar funds

Raymond James & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Raymond James & Associates held 4,104 positions worth $148B, up 10% from $134B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q1 2024 filing shows 267 new, 1,933 increased, 1,554 reduced and 192 closed positions. Its largest new stake was Veralto: 431,115 shares worth $38.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $233M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2024 buy was Veralto: 431,115 shares worth $38.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2024, an estimated $292M increase.
  • Raymond James & Associates's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $233M.
  • Raymond James & Associates fully exited Splunk Inc in Q1 2024, selling an estimated $14.6M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $148B portfolio in Q1 2024.
  • Raymond James & Associates opened 267 new positions and closed 192 in Q1 2024.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $148B.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.